Photo Credit: Beautyinthebag.com
I’ve always had an issue with my stomach. Even at my thinnest in my 20s and “wedding weight” in my early 30s, I never (ever) felt confident baring my belly in a bikini. Fast forward to almost 20 years later at the age of 42, I do Pilates six days a week—and while I’m definitely in the best shape of my life, I still see room for abdominal improvement. When Emsculpt received FDA clearance last year I immediately became obsessed, and as it turns out I’m the ideal candidate.
After about 1,000 attempts, this is the most flattering “before” photo I took.
The first treatment of its kind, Emsculpt uses HIFEM
Photo Credit: emsculpt.com
May 20-24 is National #EMSCULPTWeek—and there’s no better way to kick off summer (and with a tighter, more toned body at that)! Officially available for one year, this innovative energy-based treatment is the first of its kind to enhance the definition of abdominal and buttocks muscles while reducing the thickness of overlying fat as well, and it’s safe to say that it’s been a huge hit. Since Emsculpt is “making strong the new sexy,” they thought it was only fitting to declare their own National Week (and it’s now an officially registered week on the National Day calendar).
The Emsculpt treatment utilizes HIFEM (or high-intensity focused electromagnetic energy) to simulate the ef
Photo Credit: Pexels.com
Just in time for Spring, the U.S. Food and Drug Administration has issued a proposed rule that would update regulatory requirements for many sunscreen products.This is aimed at bringing nonprescription, over-the-counter (OTC) sunscreens that are marketed without FDA-approvals up to date with the latest science. Their hope is to ensure that consumers understand the criteria for effective sun care options, active ingredients dosage forms, SPF and broad-spectrum requirements.
The FDA also proposes labeling updates to make it easier for consumers to identify key product information. Broad spectrum sunscreens with SPF of at least 15 are considered mandatory for preventing skin cancer and prote
Photo Credit: depositphotos.com
At long last, the much anticipated Jeuveau (TM) from Evolus received a nod from the US FDA.
Evolus (EOLS) is a relatively new medical aesthetics company with a stellar team of aesthetics industry veterans to their credit, who have brought the first 900 kDA botulinum toxin (DWP-450) – touted to be the same as BOTOX (Allergan) – to market. It hails from Daewong Bio Inc in Seoul, South Korea, which is fast become the de facto capital of all things aesthetic in Asia, and Evolus has exclusive rights to this toxin for the US market.
According to New York City plastic surgeon Z. Paul Lorenc, MD, who was an investigator for the Phase II and Phase III studies for Evolus, “We found that the safe